Kiltearn Partners LLP Mckesson Corp Transaction History

Kiltearn Partners LLP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 13, 2020	SELL	$130.23 - $153.27 $146 Million - $172 Million	-1,118,962 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$134.24 - $148.53 $81.7 Million - $90.4 Million	-608,600 Reduced 35.23%	1,118,962 $152 Million
Q2 2019 Jul 30, 2019	SELL	$112.47 - $134.93 $18.9 Million - $22.6 Million	-167,800 Reduced 8.85%	1,727,562 $232 Million
Q1 2019 May 14, 2019	SELL	$111.86 - $136.3 $25.2 Million - $30.7 Million	-225,389 Reduced 10.63%	1,895,362 $222 Million
Q4 2018 Feb 08, 2019	BUY	$108.23 - $136.84 $8.67 Million - $11 Million	80,100 Added 3.93%	2,120,751 $234 Million
Q3 2018 Nov 13, 2018	BUY	$123.14 - $138.52 $21 Million - $23.7 Million	170,753 Added 9.13%	2,040,651 $271 Million
Q2 2018 Aug 13, 2018	SELL	$133.4 - $158.13 $6 Million - $7.12 Million	-45,000 Reduced 2.35%	1,869,898 $249 Million
Q1 2018 May 14, 2018	BUY	$138.75 - $176.72 $15.7 Million - $19.9 Million	112,800 Added 6.26%	1,914,898 $269 Million
Q4 2017 Feb 13, 2018	BUY	$135.02 - $162.6 $54.4 Million - $65.5 Million	402,566 Added 28.76%	1,802,098 $281 Million
Q3 2017 Nov 13, 2017	BUY	$146.0 - $161.87 $204 Million - $227 Million	1,399,532	1,399,532 $215 Million

1,713

112M

871K

900K

Ticker MCK
Exchange NYSE
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 143,730,000
Market Cap $75.6B
Description
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...

Get notified when there are updates to the investment portfolio of Kiltearn Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Kiltearn Partners LLP with notifications on news.